Hip joint disease
Conditions
Interventions
Traditional surgery group:Traditional total hip replacement
Experimental group:the navigation system for total hip replacement surgery
Sponsors
Affiliated Hospital of Jining Medical University
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. End-stage hip joint diseases such as degenerative osteoarthritis, traumatic arthritis or avascular necrosis, inflammatory joint disease, femoral neck fracture and hip fracture failure after internal fixation, total hip prosthesis replacement is required; 2. Aged 50 to 80 years; 3. Subjects or guardians are willing and able to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Ankylosis of the hip joint; 2. Congenital hip dysplasia (Crowe IV); 3. Patients with neuromuscular insufficiency (eg: paralysis, myolysis or muscle weakness) can lead to postoperative hip instability or abnormal gait; 4. Suffering from an underlying medical condition (including but not limited to metabolic, hematological, renal, hepatic, pulmonary, neurological, endocrine, cardiac, infectious or gastrointestinal) in the opinion of the investigator that the patient is at unacceptable risk; currently suffering from Severely progressive or uncontrolled disease that is inappropriate for the trial or puts it at high risk, including any medical or psychiatric condition that the investigator believes will prevent the subject from following the protocol or completing the study according to the protocol; 5. Suffering from progressive infection or malignant disease, can produce chest X-ray, computed tomography (CT scan) or MRI evidence within 12 weeks before screening, and it has been confirmed by qualified physician evaluation; 6. Active systemic infection (except colds) within the previous two weeks or any other infection that recurs regularly; 7. History of chronic or recurrent infectious diseases, or evidence of positive tuberculosis infection at screening. Subjects with positive or inconclusive results were eligible to participate in the study if they had undergone a comprehensive tuberculosis test (as per local practice/guidelines) within the 12 weeks prior to baseline and were ultimately confirmed to have no evidence of active tuberculosis. If latent TB is confirmed, treatment must be initiated and maintained prior to baseline in accordance with local or national guidelines; 8. The patient is mentally incapable or unable to understand the requirements of participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Baseline data of research subjects;Pain VAS Score; | — |
Countries
China
Contacts
Public ContactWang Guodong
Affiliated Hospital of Jining Medical University
Outcome results
None listed